![Office of National Drug Control Policy / Pharmacology / Carbamates / Clinical pharmacology / Drug Enforcement Administration / Synthetic cannabis / Controlled Substances Act / Title 21 of the Code of Federal Regulations / Gil Kerlikowske / Drug policy of the United States / Medicine / Government Office of National Drug Control Policy / Pharmacology / Carbamates / Clinical pharmacology / Drug Enforcement Administration / Synthetic cannabis / Controlled Substances Act / Title 21 of the Code of Federal Regulations / Gil Kerlikowske / Drug policy of the United States / Medicine / Government](https://www.pdfsearch.io/img/fd5a2247d682685a89500f1cf5e30dca.jpg) Date: 2013-01-22 11:51:11Office of National Drug Control Policy Pharmacology Carbamates Clinical pharmacology Drug Enforcement Administration Synthetic cannabis Controlled Substances Act Title 21 of the Code of Federal Regulations Gil Kerlikowske Drug policy of the United States Medicine Government | | NASCSA BREAKING NEWS DEA Places Ezogabine in Schedule V The Drug Enforcement Administration (DEA) has issued a final rule to place Ezogabine into Schedule V of the Controlled Substance Act effective December 15, 2011. EzAdd to Reading ListSource URL: www.nascsa.orgDownload Document from Source Website File Size: 79,56 KBShare Document on Facebook
|